24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME.
Clinical trial NCT02878681 · WITHDRAWN
Trial details
- NCT number
- NCT02878681
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.